Market revenue in 2023 | USD 1,024.1 million |
Market revenue in 2030 | USD 1,477.6 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 73.62% in 2023. Horizon Databook has segmented the Italy high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
According to World Bank, in 2019, over 23% of the population in Italy is aged over 65, and this percentage is expected to grow in the coming years. Increasing geriatric population is expected to boost the demand for treatment of age-related disorders, such as Alzheimer’s and Parkinson’s disease.
In October 2018, Cambrex Corporation, a key player in the market, announced that it will expand the efficacy and capacity of its Italian HPAPI manufacturing site by investing USD 3 million. Moreover, Cambrex increased the capacity of the site in 2017. This indicates an increase in the demand for HPAPI in the country.
The country is also witnessing an increase in the incidence of obesity and diabetes, which is driving the market by increasing the demand for biologics. The cancer rate in Italy is 290.6 per 100,000 population, which is expected to fuel the demand for anti-cancer drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Italy high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account